Literature DB >> 10487610

Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.

S Coutier1, L Bezdetnaya, S Marchal, V Melnikova, I Belitchenko, J L Merlin, F Guillemin.   

Abstract

Photodynamic activation of macrophage-like cells contributes to an effective outcome of photodynamic therapy (PDT) treatment. The possibility for an enhancement of macrophage activity by photosensitization with meta-tetra(hydroxyphenyl)chlorin (mTHPC) (1 microg ml(-1)) was studied in U937, monocyte cell line differentiated into macrophages (U937) cells). Phagocytic activity of U937phi cells was evaluated by flow-cytometry monitoring of ingestion of fluorescein-labelled Escherichia coli particles. Increase in irradiation fluence up to 3.45 mJ cm(-2) (corresponding irradiation time 15 s) resulted in significant increase in fluorescence signal (145%), while at higher light fluences the signal lowered down to the untreated control values. A light energy-dependent production of tumour necrosis factor-alpha (TNF-alpha) by photosensitized macrophages was further demonstrated using the L929 assay. The maximum TNF-alpha mediated cytolysis was observed at 28 mJ cm(-2) and was 1.7-fold greater than that in control. In addition, we demonstrated a fluence-dependent increase in nitric oxide (NO) production by mTHPC-photosensitized macrophages. NO release increased gradually and reached a plateau after irradiation fluence of 6.9 mJ cm(-2). Cytotoxicity measurements indicated that the observed manifestations of mTHPC-photosensitized macrophage activation took place under the sublethal light doses. The relevance of the present findings to clinical mTHPC-PDT is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487610      PMCID: PMC2374281          DOI: 10.1038/sj.bjc.6690648

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy.

Authors:  J L Merlin; S Azzi; D Lignon; C Ramacci; N Zeghari; F Guillemin
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 2.  How does photodynamic therapy work?

Authors:  B W Henderson; T J Dougherty
Journal:  Photochem Photobiol       Date:  1992-01       Impact factor: 3.421

3.  Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light.

Authors:  N Yamamoto; S Homma; T W Sery; L A Donoso; J K Hoober
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

4.  Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.

Authors:  H L Collins; G J Bancroft
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

5.  Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative.

Authors:  N Yamamoto; J K Hoober; N Yamamoto; S Yamamoto
Journal:  Photochem Photobiol       Date:  1992-08       Impact factor: 3.421

6.  Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.

Authors:  A Asher; J J Mulé; C M Reichert; E Shiloni; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

Review 7.  Photodynamic therapy in oncology: mechanisms and clinical use.

Authors:  H I Pass
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

8.  Effects of glucocorticoids on the TPA-induced monocytic differentiation.

Authors:  T Hoff; T Spencker; A Emmendoerffer; M Goppelt-Struebe
Journal:  J Leukoc Biol       Date:  1992-08       Impact factor: 4.962

Review 9.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

10.  Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.

Authors:  H B Ris; H J Altermatt; R Inderbitzi; R Hess; B Nachbur; J C Stewart; Q Wang; C K Lim; R Bonnett; M C Berenbaum
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  6 in total

1.  Locoregional therapies of liver metastases in a rat CC531 coloncarcinoma model results in increased resistance to tumour rechallenge.

Authors:  F H van Duijnhoven; R A E M Tollenaar; O T Terpstra; P J K Kuppen
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

3.  Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro.

Authors:  Ana Flavia Popi; José Daniel Lopes; Mario Mariano
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

4.  Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro.

Authors:  Friederike Rothe; Ina Patties; Rolf-Dieter Kortmann; Annegret Glasow
Journal:  Molecules       Date:  2022-05-24       Impact factor: 4.927

5.  What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

Authors:  Chanda Bhandari; Mina Guirguis; N Anna Savan; Navadeep Shrivastava; Sabrina Oliveira; Tayyaba Hasan; Girgis Obaid
Journal:  Nano Today       Date:  2020-12-16       Impact factor: 20.722

6.  Photodynamic Therapy (PDT): PDT Mechanisms.

Authors:  Ron R Allison; Keyvan Moghissi
Journal:  Clin Endosc       Date:  2013-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.